4.1 Article

COPD Exacerbations Causes, Prevention, and Treatment

期刊

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.iac.2012.10.006

关键词

Chronic obstructive pulmonary disease; Exacerbation; Respiratory viruses; Bacteria

资金

  1. AstraZeneca
  2. Bayer
  3. Boehringer Ingelheim
  4. Chiesi
  5. GlaxoSmithKline
  6. Pfizer

向作者/读者索取更多资源

The mechanisms of chronic obstructive pulmonary disease exacerbation are complex. Respiratory viruses (in particular rhinovirus) and bacteria play a major role in the cause of these events. A distinct group of patients seems susceptible to frequent exacerbations, irrespective of disease severity, and this phenotype is stable over time. Many current therapeutic strategies help reduce exacerbation frequency. Further work is required to develop novel anti-inflammatory therapies for exacerbation prevention and treatment. This article focuses on the cause of chronic obstructive pulmonary disease exacerbations, and the current preventative and acute interventions available.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据